Wednesday, 9 October 2019

New Phase III Trial Evaluates Devimistat Plus FOLFIRNOX in Metastatic Pancreatic Cancer - Targeted Oncology

New Phase III Trial Evaluates Devimistat Plus FOLFIRNOX in Metastatic Pancreatic Cancer  Targeted Oncology
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)